Enhancement of cocaine-induced hyperthermia fails to elicit neurotoxicity

被引:22
作者
Cappon, GD
Morford, LL
Vorhees, CV
机构
[1] Childrens Hosp Res Fdn, Div Dev Biol, Grad Program Neurosci, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA
关键词
cocaine; hyperthermia; dopamine; rat; neurotoxicity; GFAP;
D O I
10.1016/S0892-0362(98)00004-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neurotoxic potential of cocaine when administered under conditions conducive to the initiation of hyperthermia was investigated. Rats were administered cocaine at ambient temperatures of 22 degrees C or 30 degrees C. To determine the thermal response, body temperatures were measured every 30 min and the total thermal response (TTR), representing the area under the temperature vs. time curve, was calculated. Saline administered at 22 degrees C or 30 degrees C resulted in a normal thermal response (TTR = 9.8 +/- 0.9 and 11.2 +/- 0.9, respectively). Cocaine administration resulted in ambient temperature-dependent hyperthermia. Cocaine (4 x 25 mg/kg) administered at 22 degrees C resulted in a TTR of 15.1 +/- 0.9 whereas cocaine (4 x 15 or 25 mg/kg) administered at 30 degrees C resulted in TTRs of 22.2 +/- 0.9 and 21.9 +/- 0.8, respectively. Regardless of the dose or thermal response, cocaine administration did not result in depletion of dopamine (DA) or serotonin (5-HT) in the caudate-putamen. Cocaine administration also failed to induce an increase in the concentration of glial fibrillary acidic protein (GFAP), a marker for neurotoxicity. These results demonstrate that hyperthermia does not promote cocaine-induced neurotoxicity in the rat caudate-putamen. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:531 / 535
页数:5
相关论文
共 53 条
[41]  
SCHMIDT CJ, 1985, J PHARMACOL EXP THER, V233, P539
[42]   MEASUREMENT OF PROTEIN USING BICINCHONINIC ACID [J].
SMITH, PK ;
KROHN, RI ;
HERMANSON, GT ;
MALLIA, AK ;
GARTNER, FH ;
PROVENZANO, MD ;
FUJIMOTO, EK ;
GOEKE, NM ;
OLSON, BJ ;
KLENK, DC .
ANALYTICAL BIOCHEMISTRY, 1985, 150 (01) :76-85
[43]  
SONSALLA PK, 1991, J PHARMACOL EXP THER, V256, P506
[44]   ROLE FOR EXCITATORY AMINO-ACIDS IN METHAMPHETAMINE-INDUCED NIGROSTRIATAL DOPAMINERGIC TOXICITY [J].
SONSALLA, PK ;
NICKLAS, WJ ;
HEIKKILA, RE .
SCIENCE, 1989, 243 (4889) :398-400
[45]   METHAMPHETAMINE-INDUCED NEUROTOXICITY - ROLES FOR GLUTAMATE AND DOPAMINE EFFLUX [J].
STEPHANS, SE ;
YAMAMOTO, BK .
SYNAPSE, 1994, 17 (03) :203-209
[46]   AMPHETAMINE AND OTHER WEAK BASES ACT TO PROMOTE REVERSE TRANSPORT OF DOPAMINE IN VENTRAL MIDBRAIN NEURONS [J].
SULZER, D ;
MAIDMENT, NT ;
RAYPORT, S .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) :527-535
[47]   LONG-LASTING DEPLETIONS OF STRIATAL DOPAMINE AND LOSS OF DOPAMINE UPTAKE SITES FOLLOWING REPEATED ADMINISTRATION OF METHAMPHETAMINE [J].
WAGNER, GC ;
RICAURTE, GA ;
SEIDEN, LS ;
SCHUSTER, CR ;
MILLER, RJ ;
WESTLEY, J .
BRAIN RESEARCH, 1980, 181 (01) :151-160
[48]  
WALL SC, 1995, MOL PHARMACOL, V47, P544
[49]   L-DOPA PRETREATMENT POTENTIATES STRIATAL DOPAMINE OVERFLOW AND PRODUCES DOPAMINE TERMINAL INJURY AFTER A SINGLE METHAMPHETAMINE INJECTION [J].
WEIHMULLER, FB ;
ODELL, SJ ;
MARSHALL, JF .
BRAIN RESEARCH, 1993, 623 (02) :303-307
[50]   MK-801 PROTECTION AGAINST METHAMPHETAMINE-INDUCED STRIATAL DOPAMINE TERMINAL INJURY IS ASSOCIATED WITH ATTENUATED DOPAMINE OVERFLOW [J].
WEIHMULLER, FB ;
ODELL, SJ ;
MARSHALL, JF .
SYNAPSE, 1992, 11 (02) :155-163